More and more, the quality of real-world evidence (RWE)—gathered from remote patient monitoring data, product and disease registry data, and patient feedback—determines whether a medical device is approved and, in some instances, for how long. Yet some medical device manufacturers are missing an important opportunity to collaborate with clinical registries in capturing this data and driving value.
Correct usage of codes impacts product positioning, pricing, launch and customer support.
How do marketing messages affect third-party payers?
That depends on where you sit.
Payer organizations face a host of issues in the conversion to ICD-10.
Identify the roadmap through which you’re evolving with the changing healthcare landscape.
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
Successful accountable care organizations consist of a superior confluence of quality efforts, physician engagement, patient engagement, the right administration and the ability to keep costs down. The challenge comes in balancing these efforts while keeping costs to a minimum.
Success metrics in an accountable care organization (ACO) can be extensive in scope, from quality to cost to utilization to patient satisfaction—and all of these factors are important.
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.